Patents by Inventor Akazienweg Wiegand Lang

Akazienweg Wiegand Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody which is specific for activated coagulation factor VII, and its use
    Publication number: 20030003096
    Abstract: A monoclonal antibody has been developed which only specifically binds activated factor VII, and not factor VII, and which does not bind to an activated factor VII which is complexed with antithrombin III. This monoclonal antibody is isolated from the hybridoma cell line DSM ACC 2332. It can be used for qualitatively and quantitatively detecting factor VIIa in body fluids, blood coagulation preparations or the intermediate stages in the production of these preparations, on cell surfaces or in tissues, and can also be used as a humanized monoclonal antibody in therapeutic preparations.
    Type: Application
    Filed: August 23, 2002
    Publication date: January 2, 2003
    Applicant: Aventis Behring GmbH.
    Inventors: Sonnenhang Jurgen Romisch, Akazienweg Wiegand Lang, Langewiesenweg Annette Feussner, Hohenweg Joachim Roder